MORE►
Johnson & Johnson
Lisa Paley [Photo: LinkedIn]
Revision Skincare Names Former J&J and Pfizer Exec as Its New CEO
by Lance Murray | Sep 25, 2025
Lisa Paley will leverage her expertise building strong consumer brands in the United States and globally to reinvigorate the company’s business and unlock its full potential, Revision said.
by Maddie Preston |
Aug 8, 2025
The funding supports UT Arlington researcher Junzhou Huang, whose team recently ranked first in protein contact prediction and placed sixth overall in an international AI challenge competing against Google DeepMind, the University of Washington, and others.
MORE►
by Lance Murray |
Apr 18, 2023
Coppell-based Sonrava Health announced that supply chain veteran Peter “Pete” Brown has joined the company as senior vice president of supply chain.
Sonrava Health is a national family of health and wellness companies — including differentiated dental office brands, dental and vision benefit plans, provider networks, and consumer products and services — focused on quality, value, and innovation....
MORE►
by Lance Murray |
Nov 18, 2022
Oray Boston is the worldwide president of trauma, extremities, craniomaxillofacial, and animal health at DePuy Synthes, the orthopedics company of Johnson & Johnson.
MORE►
Top 10 rankings from the Brand Finance Global 500 2022 Report. [Image: Global Finance]
With Americas HQ in Dallas, U.K.’s Brand Finance Releases 2022 Global 500 Rankings
by David Seeley | Jan 27, 2022
Some insights: TikTok is the world's fastest-growing brand; tech is the most valuable industry at $1.3 trillion; retail continues to thrive with Walmart jumping up a spot; the pharma sector showed faster growth over the last two years than any other; and the U.S. and China continue to dominate.
We spoke with the managing director of the company's Dallas Americas HQ about his firm's Texas business and plans for U.S. growth.
MORE►
by Quincy Preston |
Aug 20, 2020
OncoNano Medicine, a spinout of University of Texas Southwestern, uses pH as a biomarker to detect metastatic cancer. Its technology, which visualizes a tumor, could be a gamechanger.
MORE►
by Alex Edwards |
Jul 13, 2020
CAGE Bio—currently a resident at Johnson & Johnson Innovation—uses a proprietary platform to develop therapeutic products for dermatology, inflammation, and immunology.
MORE►
by Nicholas Sakelaris |
Oct 13, 2017
From the future of Cancer Prevention & Research Institute of Texas grants to patient records innovation, leaders discussed issues facing the industry.
MORE►
